📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Mitochondria-targeted hydrogen sulfide donor reduces atherogenesis by changing macrophage phenotypes and increasing UCP1 expression in vascular smooth muscle cells. (2024)

First Author: Stachowicz A

Attributed to: DOES MITOCHONDRIA-TARGETED HYDROGEN SULFIDE PREVENT AND/OR REVERSE CIGARETTE SMOKE-INDUCED LUNG INJURY? IMPLICATIONS FOR COPD. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.biopha.2024.117527

PubMed Identifier: 39405912

Publication URI: http://europepmc.org/abstract/MED/39405912

Type: Journal Article/Review

Volume: 180

Parent Publication: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

ISSN: 0753-3322